GILEAD Aktie

 

In the closing of the recent trading day, Gilead Sciences (GILD) stood at $129.83, denoting a -3.72% move from the preceding trading day....

MOUNT GILEAD, N.C., July 8, 2026 /PRNewswire/ -- On June 26, 2026, McRae Industries, Inc. received a contract award from the United States Government DLA Troops Support for Marine temperate weather combat boots. This is a firm fixed price, indefinite delivery/indefinite quantity contract......

Gilead wins FDA approval to expand Trodelvy into first-line mTNBC, boosting its market reach and strengthening its oncology growth strategy....

Pre-Market Stock Futures: Futures are trading mixed as we get ready to start the first full week of trading for the third quarter, as traders and investors return from the long 4th of July holiday. With second-quarter earnings starting this week, and with all of the major indices trading at or near all-time highs, you ... Here Are Monday's Best Wall Street Analyst Research Calls: Agnico Eagle Mines, Datadog, Delta Air Lines, Gilead Sciences, Okta, Pfizer, Regions Financial, T-Mobile, and More...

O'day, Daniel Patrick - Vorstand - Tag der Transaktion: 2026-07-01...

Gilead (GILD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects....

Statthalter des Kalifornien-Riesen stellt Schweizer Seniors vor Tür, ersetzt sie mit Expat-Juniors. Stress im Biz: Konkurrenz holt auf. Die Gilead zählt in der Pharma-Branche zu den grossen Namen. In der Schweiz hingegen kennt man das US-Biotech-Unternehmen weniger. Am Swiss Sitz in Zug beschäftigt die Firma rund 70 Leute – „spezialisierte Mitarbeitende, die echte Partnerinnen und Partner für die […]...

Gilead (GILD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term....

In the closing of the recent trading day, Gilead Sciences (GILD) stood at $123.84, denoting a -1.05% move from the preceding trading day....

GILD wins FDA approval to expand Trodelvy into first-line metastatic triple-negative breast cancer, opening a broader treatment opportunity....

FOSTER CITY (dpa-AFX) - Gilead Sciences Inc. (GILD) said Thursday that the U.S. Food and Drug Administration has approved Trodelvy for the first-line treatment of adults with unresectable locally ......

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

Gilead secures EC approval to expand Trodelvy into first-line metastatic TNBC, marking a new treatment option and broadening its oncology reach....

FOSTER CITY (dpa-AFX) - Tuesday, Gilead Sciences, Inc. (GILD) announced that the European Commission has granted marketing authorization for Trodelvy, also known as sacituzumab govitecan-hziy, as ......

Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects....

Importance Rank:  1 read more...

Gilead Sciences won FDA acceptance for a filing that could expand Yeztugo into a once-weekly oral HIV prevention option, broadening its HIV portfolio....

Dickinson, Andrew D. - Vorstand - Tag der Transaktion: 2026-06-15...

Mercier, Johanna - Vorstand - Tag der Transaktion: 2026-06-15...

Gilead seeks FDA approval for once-weekly oral Yeztugo for HIV prevention, aiming to expand access with a new long-acting PrEP option....